wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33556988-2127A53E-F4BF-4BAD-B8C3-6F7D73A1F43E
Q33556988-2127A53E-F4BF-4BAD-B8C3-6F7D73A1F43E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556988-2127A53E-F4BF-4BAD-B8C3-6F7D73A1F43E
A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors.
P2860
Q33556988-2127A53E-F4BF-4BAD-B8C3-6F7D73A1F43E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556988-2127A53E-F4BF-4BAD-B8C3-6F7D73A1F43E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f3c55cf12cf3a67ba87021969f2434814dafbd0
P2860
Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors.